Author Index
Search or browse for an author across our entire electronic archive
Search results for: O
Results 1 - 10 of 688 shown below
O'Brien, M E R
R Mendes, M E R O'Brien, A Mitra, A Norton, R K Gregory, A R Padhani, K V Bromelow, A R Winkley, S Ashley, I E Smith and B E Souberbielle
Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma
doi:10.1038/sj.bjc.6600063
Abstract | Full article | PDF
-
J S Waters and M E R O'Brien
The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence (NICE)
doi:10.1038/sj.bjc.6600491
Abstract | Full article | PDF
-
P J Ross, S Ashley, A Norton, K Priest, J S Waters, T Eisen, I E Smith and M E R O'Brien
Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?
advance online publication, 2004-04-20 00:00:00.000;
doi:10.1038/sj.bjc.6601781
Abstract | Full article | PDF
-
P J Barrett-Lee, N P Bailey, M E R O'Brien and E Wager
Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy
doi:10.1054/bjoc.1999.0883
O'Brien, S G
S G O'Brien, P Meinhardt, E Bond, J Beck, B Peng, C Dutreix, G Mehring, S Milosavljev, C Huber, R Capdeville and T Fischer
Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia
doi:10.1038/sj.bjc.6601152
Abstract | Full article | PDF
O'Brien, T J
A D Santin, F Zhan, S Bellone, M Palmieri, S Cane, M Gokden, J J Roman, T J O'Brien, E Tian, M J Cannon, J Shaughnessy and S Pecorelli
Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling
doi:10.1038/sj.bjc.6601791
Abstract | Full article | PDF
O'Byrne, J
J A Glaspy, J S Jadeja, G Justice, J Kessler, D Richards, L Schwartzberg, N S Tchekmedyian, S Armstrong, J O'Byrne, G Rossi and A B Colowick
Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy
doi:10.1038/sj.bjc.6600465
Abstract | Full article | PDF
O'Byrne, K J
K J O'Byrne, A L Thomas, R A Sharma, M DeCatris, F Shields, S Beare and W P Steward
A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer
doi:10.1038/sj.bjc.6600344
Abstract | Full article | PDF
-
J G Edwards, J McLaren, J L Jones, D A Waller and K J O'Byrne
Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura
doi:10.1038/sj.bjc.6600920
Abstract | Full article | PDF
O'Callaghan, A
P A Whitehouse, S J Mercer, L A Knight, F Di Nicolantonio, A O'Callaghan and I A Cree
Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C
doi:10.1038/sj.bjc.6601403
Abstract | Full article | PDF
O'Connell, J
A Houston, M W Bennett, G C O'Sullivan, F Shanahan and J O'Connell
Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-
expressiondoi:10.1038/sj.bjc.6601240
Abstract | Full article | PDF
O'Doherty, A M
A M O'Doherty, S W Church, S E H Russell, J Nelson and I Hickey
Methylation status of oestrogen receptor-
gene promoter sequences in human ovarian epithelial cell linesdoi:10.1038/sj.bjc.6600028
Abstract | Full article | PDF
O'Donnell, A
P Beale, I Judson, A O'Donnell, J Trigo, C Rees, F Raynaud, A Turner, L Simmons and L Etterley
A Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473)
doi:10.1038/sj.bjc.6600854
Abstract | Full article | PDF
O'Donnell, D
B Ortel, D Sharlin, D O'Donnell, A K Sinha, E V Maytin and T Hasan
Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells
doi:10.1038/sj.bjc.6600575
Abstract | Full article | PDF
